DIOPTRA Project’s Post

A Horizon Europe project, aiming to revolutionise Colorectal Cancer screening via a holistic, personalised and accessible method for early detection. ⬇️

𝗨𝗸𝗿𝗮𝗶𝗻𝗲'𝘀 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗦𝗲𝗰𝘁𝗼𝗿: 𝗥𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝘁, 𝗥𝗲𝗹𝗶𝗮𝗯𝗹𝗲, 𝗮𝗻𝗱 𝗥𝗲𝗮𝗱𝘆 𝗳𝗼𝗿 𝗠𝗼𝗿𝗲 Despite ongoing challenges, the sector is demonstrating remarkable resilience and growth. Here are some key highlights from the latest European Business Association report: 🚀 New trial submissions up 120% in Q1 2024 🏥 349 new trial sites approved since May 2022 ✅ 100% of surveyed sites adapted to current conditions 🌟 94% of sites report stable or increasing patient numbers Leading global sponsors are recognizing Ukraine's potential: ● 33 international sponsors have expanded their trials to new sites ● 75 new trials have been approved since May 2022 The regulatory environment is also improving: ● Faster approval timelines (30-day evaluation period) ● New legislation harmonizing with EU standards ● Improved logistics and monitoring capabilities Ukraine's clinical research ecosystem is proving its ability to deliver high-quality data and ensure patient safety, even in challenging circumstances. As more sponsors return to Ukraine, they're finding a sector that's not just surviving, but thriving. https://lnkd.in/dt3PCtdj

After the atrocities performed by doctors during the Second World War in human experimentation and clinical research, the world was deeply shaken. The reaction was that representatives from several countries met in Helsinki, capital of Finland, through a World Medical Association (WMA) to put ethical limits in health care in writing. Thus was born the Declaration of Helsinki in 1964, with universal principles that now guide researchers, ethics committees and governments around the world in their decisions. The Declaration's operating principles include careful assessment of risks and benefits, the likelihood of benefit to the population studied, and conduct by expert investigators. And to ensure that it continues to fulfil its purpose, the WMA invites periodic reviews of the document. The last one was in 2013 and it will be reviewed again this year. In order to make the process collaborative, transparent and inclusive, a multinational working group was chosen and has two years to meet, discuss, ask for feedback and finally update it.  The second public comment period is open today (3-24 June) on the working group's proposed edits. If you want to know more details and even participate in the process, the WMA has forms and emails here: https://lnkd.in/eP-9Jmat #Helsinki #ethics #WMA #clinicaltrial #clinicalresearch #BOPALcro #CRO 

Swiss Days (Day 1): Tashkent, Uzbekistan The MESCA Foundation's mission to improve the quality of and access to #healthcare for the citizens of #CentralAsia. This #foundation is supported by 4 pillars: #education & #training, #access to #technology, #outreach and #research. Since research is fundamental to help MESCA achieve it's #mission, I requested support from the governmental sector to help make the ethical committee pathway more transparent. #Uzbekistan has the potential of conducting high impact research, but the process is not an easy one to navigate. Being a panelist at the Health: Innovation, Quality and Trust Symposium at the annual #swissdays congress, I wanted to take the opportunity to be heard of this great need. The concept is if we can make the process to submit for #clinicaltrials in Uzbekistan a lot easier, then the possibility of entering the international stage to support the advancement of #medicine is greater. To support the mission of MESCA, I feel it is the foundation's responsibility to develop a systematic approach to allow research to be conducted in Uzbekistan.

At the beginning of 2024, 309 clinical trials started, out of 400 registered - a huge 64% increase on the number of trials which started in 2023. Also, the number of local ethics commission increased from 308 in 2022 to 390 in 2023. (𝘚𝘰𝘶𝘳𝘤𝘦, 𝘚𝘵𝘢𝘵𝘦 𝘌𝘹𝘱𝘦𝘳𝘵 𝘊𝘦𝘯𝘵𝘦𝘳 𝘰𝘧 𝘵𝘩𝘦 𝘔𝘪𝘯𝘪𝘴𝘵𝘳𝘺 𝘰𝘧 𝘏𝘦𝘢𝘭𝘵𝘩 𝘑𝘢𝘯𝘶𝘢𝘳𝘺 2024 𝘳𝘦𝘱𝘰𝘳𝘵). Ukraine has persevered as a top-class clinical trials hub through the most trying times for many reasons including a resilient infrastructure, committed staff, improvements in regulation, cost effectiveness and international collaboration. We, too, are 100% committed to persevering in supporting patients in Ukraine. Our infrastructure and dedicated team have continued to operate countrywide distribution services and support named patient programs from our HQ in Kyiv, led by Igor Khytrychenko who says:  “Looking forward, I am filled with optimism. Despite the challenges, there are immense opportunities for growth and development. At COREX Logistics, we are more determined than ever to use our expertise to contribute to the country's recovery and advancement. We are committed to exploring every avenue to enhance our services and support the critical sectors we serve.” #COREX #Ukraine #PharmaceuticalLogistics

Greetings from the CRSK! Save the date: the International Clinical Trials Day (ICTD) is coming up on 20 May 2024. This year's theme is "Data-centric Clinical Research." Stay tuned for more details in the coming days! #ICTD2024 #ClinicalTrials #ClinicalResearch #Kenya #Africa

🎉✨ Wúru Celebrates a Year of Innovation with Clínica Anglo Americana In October 2024, Clínica Anglo Americana partnered with Wúru to implement innovative solutions, driving cultural transformation and operational improvements. One year later, the impact is evident: over 90 physicians actively use the platform, representing 57% of users and 51% of total revenue, fostering transparency and efficiency. With real-time updates, automated data exports, and enhanced collaboration, workflows have been significantly optimized. Dr. Jorge Luis  López Del Aguila, Deputy Medical Director, highlights: "The dynamic interface makes all the difference." Wúru celebrates Clínica Anglo Americana’s commitment to operational excellence and looks forward to driving continued innovation together. 🚀 👉 Follow Wúru on LinkedIn to see how AI is transforming healthcare: linkedin.com/company/wuru #HealthcareInnovation #AIInHealthcare #DigitalTransformation #PatientCare #Wúru

📊 💡Join our upcoming webinar with Taimei Technology to delve into the promising collaboration between China and Australia in the clinical trial and biotech sectors! The expert speakers will highlight how dynamics between sites, investigators, and recruitment strategies vary across different therapy areas. Understanding these nuances is crucial for optimizing clinical trial outcomes. Through expert insights and case studies, attendees will learn practical recommendations and best practices for maximizing collaboration and ensuring successful clinical trials in Australia. ➡️ More info and registration here: https://buff.ly/3Jic3oB 🌟 Expert speakers: Tam C. Nguyen Robert Lin, MBA Nate Zhang Lisa Nelson #ClinicalTrials #ClinicalResearch #PatientRecruitment #ClinicalOperations #ClinicalSites #ClinicalTrialsAustralia #Commercialization #MarketAccess #CTLogistics

From Quacks to Qualified Care: How Medical Media is Revolutionizing Healthcare Access Ever wondered how people find top-notch doctors these days? We often start by asking friends and family or colleagues at work, hoping they know a trusted specialist. But what if the answer isn't found in our social circles? We turn to the internet, where we sift through reviews and ratings to find the best medical advice. However, the founders of MedicalMedia.Kazakhstan believe there's still a long way to go. With only 2% of medical professionals having an online presence, and the risk of encountering fake reviews, finding a reliable doctor can be a daunting task. MedicalMedia.Kazakhstan aims to bridge this gap, connecting high-quality doctors with grateful patients through their innovative platform. Dive into the full story with Zaure Moldakulova and Zhansaya Narbota, the founders of MedicalMedia.Kazakhstan, on ER10.KZ on how they plan to revolutionize healthcare and safeguard us from charlatans. Click the link to read interview https://lnkd.in/d36K9_jq "100 Startup Stories of Kazakhstan" is a joint project by ER10.KZ and Astana Hub.

Choosing the right location can be the key to a successful clinical trial. Here’s why Thailand should be at the top of your list: 1️⃣ Cost-Effectiveness: Conduct rigorous trials at a fraction of the cost without compromising quality. 2️⃣ Diverse Patient Population: Access a wide range of genetic backgrounds, boosting the relevance and generalizability of your study. 3️⃣ Efficient Regulatory Process: Get faster approvals with Thailand’s streamlined regulatory environment. Want to know the other four reasons? Click the link to dive deeper into why Thailand is the ideal choice for your clinical research!🚀 https://lnkd.in/gxkrPh-i #ClinicalTrials #Research #Thailand #HealthcareInnovation #PharmaResearch